Featured Research

from universities, journals, and other organizations

Adult living donor liver transplants safe, study finds

Date:
November 8, 2011
Source:
Henry Ford Health System
Summary:
Desperately needed adult living donor liver transplantation is a safe surgery for the donor, according to researchers. The study looked at donor safety from a single center over a period of 10 years and found there were no patient deaths and no life-threatening complications requiring ICU care.

Desperately needed adult living donor liver transplantation is a safe surgery for the donor, according to researchers at Henry Ford Hospital.

The study looked at donor safety from a single center over a period of 10 years and found there were no patient deaths and no life-threatening complications requiring ICU care.

"There is a growing need for a limited number of available organs and more people are dying while waiting so we need to look at ways to continue to safely increase the organ pool," says Hemal Patel, M.D., a gastroenterologist at Henry Ford Hospital.

"In our 10-year, single-center experience, there was a 100 percent donor survival rate, and with most of the complications being low-grade, this is good news for the future of this type of transplantation."

The results of the study are being presented this week at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco.

Adult-to-adult living donor liver transplant, introduced about a decade ago, involves donation of right liver lobe usually from the recipient's relative or close friend. Living donor liver transplant provides a significant contribution to the organ pool and thus reduces wait-list morbidity and mortality.

The Henry Ford study looked at 54 living donor liver transplants performed at Henry Ford Transplant Institute between January 2000 and March 2011 and found that surgery for living donors is not a source of mortality, with most donors having only minor complications.

While no serious complications or deaths were noted, researchers found approximately 61% minor complications in 54 donors and 25% re-hospitalizations after surgery, all for minor reasons. Also noted was, 26% of those low-grade complications required either surgical (3.7%), endoscopic (11.1%) or radiological (5.5%) interventions. Other complications were self-limiting or improved with pharmacological interventions only.

Average length of surgery for donors was 6.19 hours; the mean length of hospital stay was 6.72 days; and only 7 percent of the donors undergoing surgery required blood transfusion.

All the liver donors in this 10-year analysis returned back to their lives and work.

"Careful donor selection, donor education and meticulous surgical and post-surgical care are necessary to reduce donor morbidity," says Dr. Patel.

Potential donors at the Institute undergo pre-operative medical and surgical consultation as well as psychosocial assessment.

The study was funded by Henry Ford Hospital.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Adult living donor liver transplants safe, study finds." ScienceDaily. ScienceDaily, 8 November 2011. <www.sciencedaily.com/releases/2011/11/111108132909.htm>.
Henry Ford Health System. (2011, November 8). Adult living donor liver transplants safe, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/11/111108132909.htm
Henry Ford Health System. "Adult living donor liver transplants safe, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/11/111108132909.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins